Role of quercetin and L-arginine in alleviating zinc oxide nanoparticle hepatotoxicity in rats

Chiang Mai Journal of Science

Volumn 40, Issue 4, 2013, Pages 577-592

  Abdel Baky, Nayira A ^a   Faddah, L M ^a   Al Rasheed, Nouf M ^a   Al Rasheed, Nawal M ^a   Shebali, Wedad ^a  

^a KING SAUD UNIVERSITY   (Saudi Arabia)

Author keywords

Antioxidants; Deoxyribonucleic acid 2; Tumor necrosis factor 3 proinflammatory cytokines; Zinc oxide nano particles 1

Indexed keywords

EID: 84888079074     PISSN: 01252526     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (80)

1. Borm P.J., Robbins D., Haubold S., Kuhlbusch T., Fissan H., Donaldson K., et al., The Potential Risks of Nanomaterials: A Review Carried Out For ECETOC. Part Fibre Toxicol., 2006; 3-11.
2. Nohynek G.J., Lademann J., Ribaud C., Roberts M.S., Grey goo on the skin? nanotechnology, cosmetic and sunscreen safety, Crit. Rev. Toxicol., 2007; 37(3): 251-277.
3. Maynard A.D., Aitken R.J., Butz T., Colvin V., Donaldson K., Oberdorster G., Safe handling of nanotechnology, Nature, 2006; 444(7117): 267-269.
4. Nel A., Xia T., Madler L., Li N., Toxic potential of materials at the nano level, Sci., 2006; 311(5761): 622-627.
5. Environmental Protection Agency 2007. Science Policy Council, Nanotechnology Workgroup Nanotechnology White Paper.
6. Wang Z.L. Zinc oxide nanostructures: growth, properties and applications, J. Phys. Condens. Matter., 2004; 16: 829-858.
7. Berube D.M. Rhetorical Gamesmanship in The Nano Debates Over Sunscreens and Nanoparticles. J Nanopart. Res., 2008; 10: 23-37.
8. Beckett W.S., Chalupa D.F., Pauly-Brown A., Speers D.M., Stewart J.C., Frampton M.W., Utell M.J., Huang L.S., Cox C., Zareba W., Oberdorster G., Comparing inhaled ultrafine versus fine zinc oxide particles in healthy adults: A human inhalation study, Am. J. Respir. Crit. Care Med., 2005; 171(10): 1129-1135.
9. Lam H.F., Conner M.W., Rogers A.E., Fitzgerald S., Amdur M.O., Functional and morphologic changes in the lungs of guinea pigs exposed to freshly generated ultrafine zinc oxide, Toxicol. Appl. Pharmacol., 1985; 78(1): 29-38.
10. Gojova A., Guo B., Kota R.S., Rutledge J.C., Kennedy I.M., Barakat A.I., Induction of inflammation in vascular endothelial cells by metal oxide nanoparticles: Effect of particle composition, Environ. Health Perspect., 2007; 115(3): 403-409.
11. Lin W.S., Xu Y., Huang C.C., Ma Y., Shannon K.B., Chen D.R., Huang Y.W. Toxicity of nano- and micro-sized ZnO particles in human lung epithelial cells, J. Nanopart. Res., 2009; 11: 25-29.
12. Wang B., Feng W.Y., Wang M., Wang T.C., Gu Y.Q., Zhu M.T., Ouyang H., Shi J.W., Zhang F., Zhao Y.L., Chai Z.F., Wang H.F., Wang J., Acute toxicological impact of nano- and submicro-scaled zinc oxide powder on healthy adult mice, J. Nanopart. Res., 2008; 10(2): 263-276.
13. Lovern S.B., Klaper R., Daphnia magna mortality when exposed to titanium dioxide and fullerene (C60) nanoparticles, Environ. Toxicol. Chem., 2006; 25: 1132-7.
14. Franklin N.M., Rogers N.J., Apte S.C., Batley G.E., Gadd G.E., Casey P.S. Comparative toxicity of nanoparticulate ZnO, bulk ZnO, and ZnCl2 to a freshwater microalga (pseudokirchneriella subcapitata): The importance of particle solubility, Environ. Sci. Technol., 2007; 4124: 8484-8490.
15. Wang Z., Zhou J., Fan J., Qiu S.J., Yu Y., Huang X.W., et al., Effect of rapamycin alone and in combination with sorafenib in an orthotopic model of human hepatocellular carcinoma, Clin. Cancer Res., 2008; 14: 5124-5130.
16. Carlson C., Hussain S.M., Schrand A.M., Braydich-Stolle L.K., Hess K.L., Jones R.L., Unique cellular interaction of silver nanoparticles: Size-dependent generation of reactive oxygen species, J. Phys. Chem. B., 2008; 112: 13608-19.
17. Ispas C., Andreescu D., Patel A., Goia D.V., Andreescu S., Wallace K.N., Toxicity and developmental defects of different sizes and shape nickel nanoparticles in zebrafish, Environ. Sci. Technol., 2009; 43: 6349-6356.
18. Mironava T., HadjiL-Argyrou M., Simon M., Jurukovski V., Rafailovich M.H., Gold nanoparticles cellular toxicity and recovery: Effect of size, concentration and exposure time. Nanotoxicol., 2010; 4:120-137.
19. Lu S., Duffin R., Poland C., Daly P., Murphy F., Drost E., Efficacy of simple short-term in vitro assays for predicting the potential of metal oxide nanoparticles to cause pulmo-nary inflammation, Environ. Health Perspect., 2009; 117: 241-247.
20. Nel A.E., Madler L., Velegol D., Xia T., Hoek E.M., Somasundaran P. Understanding biophys icochemical interactions at the nano-bio interface, Nat Mater., 2009; 8(7): 543-557.
21. Wu G.H., Zhang Y.W., Wu Z.H., Modulation of postoperative immune and inflammatory response by immuneenhancing enteral diet in gastrointestinal cancer patients., World J. Gastroentero., 2001; 7(3): 357-362.
22. Dias A.S., Porawski M., Alonso M., Marron N., Collado P.S., Gallego J.G., Qur decreases oxidative stress, NF-κB activation, and iNOS overexpression in liver of streptozotocin-induced diabetic Rats, J. Nutr. 2005; 135: 2299-2304.
23. Chana S.T., Chuangb C.H., Yehb C.L., Liaoc J.W., Liua K.L., Tsenga M.J., Yeha S.L., Qur supplementation suppresses the secretion of pro-inflammatory cytokines in the lungs of mongolian gerbils and in A549 cells exposed to benzo[a]pyrene alone or in combination with β-carotene: In Vivo and ex vivo studies, J. Nutr. Biochem. (in press).
24. Liu J., Li X., Yue Y., Li J., He T., He Y., The inhibitory effect of qur on IL-6 production by LPS-stimulated neutrophils, Cell Mol. Immunol., 2005; 2: 455-60.
25. Bischoff S.C., Qur: Potentials in the prevention and therapy of disease, Curr. Opin Clin. Nutr. Metab. Care., 2008; 11: 733-740.
26. Jung W.J. Sung M.K., Effects of major dietary antioxidant on inflammatory markers of RAW 264.7 macrophages, Biofactors, 2004; 21: 113-117.
27. Huang C.C., Tsai S.C., Lin W.T., Potential ergogenic effects of L-Arg against oxidative and inflammatory stress induced by acute exercise in aging rats, Exp. Gerontol., 2008; 43: 571-577.
28. Ivanov V., Cha J., Ivanova S., Kalinovsky T., Roomi M.W., Rath M., Niedzwiecki A., Essential nutrients suppress inflammation by modulating key inflammatory gene expression, Int. J. Mol. Med., 2008; 22: 731-741,
29. Moinard C., Cynober L. de Bandt J.P., Polyamines: Metabolism and implications in human diseases, Clin. Nutr., 2005; 24:184-197.
30. Chung D.H., Evers B.M., Townsend C.M. Jr., Role of polyamine biosynthesis during gut mucosal adaptation after burn Injury, Am. J. Surg., 1993; 165: 144-149.
31. Kambe D., Kotani M., Yoshimoto M., Kaku S., Chaki S., Honda K., Effects of qur on the sleep-wake cycle in rats: Involvement of gamma-aminobutyric acid receptor type A in regulation of rapid eye movement sleep, Brain Res., 2010; 1330: 83-88.
32. El-Missiry M.A., Othman A.I., Amer M.A., L-Arg ameliorates oxidative stress in alloxan-induced experimental Diabetes mellitus, J. Appl. Toxicol., 2004; 24(2): 93-97.
33. Kim N., Kim Y.J., Cho D.K., Gold nanoparticle-based signal augmentation of quartz crystal microbalance immunosensor measuring C-reactive protein, Curr. Appl. Phys., 2010; 10(4): 1227-1230.
34. Kaden J., IL-6 determination in serum of kidney graft recipients by a new bedside test: Its diagnostic relevance, Transplant Proc., 2007; 39(2): 511-513.
35. Miwa I., Okuda J., Maeda K., Okuda G., Mutarotase effect on colorimetric determination of blood glucose with D-glucose oxidase, Clin. Chem. Acta., 1972; 37: 538-540.
36. Singh N.P., McCoy M.T., Tice R.R., Schneider E.L., A simple technique for quantitation of low levels of DNA damage in individaul cells, Exp. Cell Res., 1988; 175: 184-191.
37. Pekkanen J., Peters A., Hoek G., Tiittanen P., Brunekreef B., de Hartog J., Heinrich J., Ibald-Mulli A., Kreyling W.G., Lanki T., Timonen K.L., Vanninen E., Particulate air pollution and risk of STsegment depression during repeated submaximal exercise tests among subjects with coronary heart disease: The exposure and risk assessment for fine and ultrafine particles in ambient air [Ultra] Study, Circulation, 2002; 106: 933-938.
38. Penttinen P., Timonen K.L., Tiittanen P., Mirme A., Ruuskanen J. and Pekkanen J., Ultrafine particles in urban air and respiratory health among adult asthmatics, Eur. Resp. J., 2001; 17(3): 428-435.
39. Xiong D., Fang T., Yu L., Sima X. and Zhu W., Effects of nano-scale TiO2, ZnO and their bulk counterparts on zebrafish: Acute toxicity, oxidative stress and oxidative damage, Sci. Total Environ., 2011; 409(8):1444-1452.
40. Von Klot S., Wolke G., Tuch T., Heinrich J., Dockery D.W., Schwartz J. and Kreyling W.G., Wichmann H.E., Peters A., Increased asthma medication use in association with ambient fine and ultrafine particles, Eur. Respir. J., 2002; 20: 691-702.
41. Rahman Q., Lohani M., Dopp E., Pemsel H., Jonas L. and Weiss D.G., Schiffman D., Evidence that ultrafine titanium dioxide induces micronuclei and apoptosis in syrian hamster embryo fibroblasts, Environ. Health Perspect., 2002; 110: 797-800.
42. Oberdörster G., Finkelstein J.N. and Johnston C., Acute pulmonary effects of ultrafine particles in rats and mice, Res. Rep. Health Eff. Inst., 2000; 96: 5-74.
43. Chen R.H., Qin R., Wang F.D., Wang J.P. and Lu T.X., The effects of oral excess zinc on the zinc level and morphology of tissues, Zhonghua Yixue Zazhi., 1992; 72(7): 391-393.
44. Wang B., Feng W.Y., Wang T.C., Jia G., Wang M., Shi J.W., Zhang F., Zhao Y.L. and Chai Z.F., Acute toxicity of nanoand micro-scale zinc powder in healthy adult mice, Toxicol. Lett., 2006; 161(2): 115-123.
45. Ding H., Peng R. and Chen J., Effects of high dietary zinc on liver function, hepatic drug metabolism enzymes and membrane fluidity in mice, Wei Sheng Yan Jiu., 1998; 27(3): 180-182.
46. Sayes C.M., Reed K.L. and Warheit D.B., Assessing toxicity of fine and nanoparticles: Comparing in vitro measurements to in vivo pulmonary toxicity profiles, Toxicol. Sci., 2007; 97: 163-180.
47. Veranth J.M., Kaser E.G., Veranth M.M., Koch M. and Yost G.S., Cytokine responses of human lung cells (BEAS- 2B) treated with micron-sized and nanoparticles of metal oxides compared to soil dusts, Particle and Fiber Toxicology, 2007; 4: 2-19.
48. Kerner A., Avizohar O., Sella R., Bartha P., Zinder O., Markiewicz W., Yishai L., Brook G.J. and Aronson D., Association between elevated liver enzymes and C-reactive protein possible hepatic contribution to systemic inflammation in the metabolic syndrome, Arterioscler. Thromb. Vasc. Biol., 2005; 25: 193-197.
49. Patel D.N., King C.A. and Bailey S.R., Interleukin-17 stimulates C-reactive protein expression in hepatocytes and smooth muscle cells via p38 MAPK and ERK1/2-dependent NF-kappaB and C/ EBPbeta activation, J. Biol. Chem., 2007; 282: 27229-27238.
50. Pepys M.B. and Baltz M.L., Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid a protein, Adv. Immunol., 1983; 34: 141-212.
51. Xi L., Xiao C., Bandsma R.H.J., Naples M., Adeli K. and Lewis G.F., C-reactive protein impairs hepatic insulin sensitivity and insulin signaling in rats: Role of mitogen- activated protein kinases, Hepatol., 2011; 53: 127-135.
52. Hattori Y., Matsumura M. and Kasai K., Vascular smooth muscle cell activation by C-reactive protein, Cardiovasc. Res., 2003; 58: 186-195.
53. D'Alessandris C., Lauro R., Presta I. and Sesti G., C-reactive protein induces phosphorylation of insulin receptor substrate-1 on Ser307 and Ser 612 in L6 myocytes, thereby impairing the insulin signaling pathway that promotes glucose transport, Diabetologia, 2007; 50: 840-849.
54. Davis, G. S., Pfeiffer, L. M. and Hemenway D. R., Persistent overexpression of interleukin-1 beta and tumor necrosis factor-alpha in murine silicosis, J. Environ. Pathol. Toxicol. Oncol., 1998; 17: 99-114.
55. Valério D.A., Georgetti S.R., Magro D.A., Casagrande R., Cunha T.M., Vicentini F.T., et al., Qur reduces inflammatory pain: Inhibition of oxidative stress and cytokine production, J. Nat. Prod., 2009; 72: 1975-1979.
56. Gauliard B., Grieve D., Wilson R., Crozier A., Jenkins C. and Mullen W.D., The effects of dietary phenolic compounds on cytokine and antioxidant production by A549 cells, J. Med. Food., 2008; 11: 382-384.
57. Tribolo S., Lodi F., Connor C., Suri S., Wilson V.G., Taylor M.A., et al., Comparative effects of qur and its predominant human metabolites on adhesion molecule expression in activated human vascular endothelial cells, Atherosclerosis, 2008; 197: 50-6.
58. Yokoyama A., Sakakibara H., Crozier A., Kawai Y., Matsui A., Terao J.K., et al., Qur metabolites and protection against peroxynitrite-induced oxidative hepatic injury in rats, Free Radic. Res., 2009; 43: 913-921.
59. Lucotti P., Monti L., Setol E., Canna G.L., Castiglioni A., Rossodivita A., Pala M.G. Formicae F., Alberico P., Catapanof L., Bosia E., Ottavio A. and Piattia M., Oral L-Arg supplementation improves endothelial function and ameliorates insulin sensitivity and inflammation in cardiopathic nondiabetic patients after an aortocoronary bypass, Metabolism Clin. Exp., 2009; 58: 1270-1276.
60. Gurr J.R.Wang A.S., Chen C.H. and Jan K.Y., Ultrafine titanium dioxide particles in the absence of phopactivation can induce oxidative DNA damage to human bronchial epithelial cells, Toxicol., 2005; 15: 66-73.
61. Agarwal S., Tafel A.A. and Kanaar R., DNA double-strand break repair and chromosome translocations, DNA Repair (Amst), 2006; 5: 1075-1081.
62. Tice R.R. and Strauss G.H.S., The single cell gel E[ectrophoresis comet assay - A potential tool for detecting radiationinduced DNA damage in humans, Stem Cells, 1995; 13(Suppl 1): 207-214.
63. Collins A.R., Dusinska M., Gedik C.M., and Stetina R., Oxidative damage to DNA: Do we have a reliable biomarker? Environ. Health Perspect., 1996; 104: 465-469.
64. Sharma V., Shukla R.K., Saxena N., Parmar D., Das M. and Dhawan A., DNA damaging potential of zinc oxide nanoparticles in human epidermal cells, Toxicol. Lett., 2009; 185: 211-218.
65. Dufour, E.K., Kumaravel, T., Nohynek, G.J., Kirkland, D. and Toutain, H., Clastogenicity, photo-clatogenicity or pseudo-photo-clastogenicity: Genotoxic effect of zinc oxide in the dark, in Preirradiatd or simultaneously irradiated Chinese hamster ovary cells, Mutat. Res., 2006; 607: 215-224.
66. Martinez G.R., Loureiro A.P., Marques S.A., Miyamoto S., Yamaguchi L.F., Onuk J., Almeida E.A., Garcia C.C., Barbosa L.F., Medeiros M.H. and Di Mascio P., Oxidative and alkylating damage in DNA, Mutat. Res., 2003; 544: 115-127.
67. Marnett L.J., Oxy radicals, lipid peroxidation and DNA damage, Toxicology, 2002; 181-182: 219-222.
68. Niedernhofer L.J., Daniels J.S., Rouzer C.A., Greene R.E. and Marnett L.J., 2003. Malondialdehyde, a product of lipid peroxidation, is mutagenic in human cells, J. Biol. Chem., 278: 31426-31433.
69. Middleton J.r. E, Kandaswami C. and Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer, Pharmacol. Rev., 2000; 52: 673-751.
70. Hanasaki Y., Ogawa S. and Fukui S., The correlation between active oxygens scavenging and antioxidative effects of flavonoids, Free Radic. Biol. Med., 1994; 16: 845-850.
71. Buettner G.R., The pecking order of Free radicals and antioxidants: Lipid peroxidation, alpha-tocopherol, and ascorbate, Arch. Biochem. Biophys., 1993; 300: 535-543.
72. Pietta P.G., Flavonoids as antioxidants, J. Nat. Prod., 2000; 63: 1035-1042.
73. Shahidi F. and Wanasundara P.K., Phenolic antioxidants, Crit. Rev. Food Sci. Nutr., 1992; 32: 67-103.
74. Duthie S.L. and Dobson V.L., Dietary flavonoids protect human colonocyte DNA from oxidative attack in vitro, Eur. J. Nutr., 1999; 38: 28-34.
75. Wilms L.C., Hollman P.C., Boots A.W. and Kleinjans J.C., Protection by qur and Qur-rich fruit juice against induction of oxidative DNA damage and formation of BPDE-DNA adducts in human lymphocytes, Mutat. Res., 2005; 582: 155-162.
76. Kochar N.I. and Umathe S.N., Beneficial effects of L-Arg against diabetesinduced oxidative stress in gastrointestinal tissues in rats, Pharmacol. rep., 2009; 61: 665-672.
77. Lass A., Suessenbacher A., Wolkart G., Mayer B. and Brunner F., Functional and analytical evidence for scavenging of oxygen radicals by L-Arg, Mol. Pharmacol., 2002; 61: 1081-1088.
78. Piacenza L., Peluffo G. and Radi R., L-Arg-dependent suppression of apoptosis in trypanosoma cruzi: Contribution of the nitric oxide and polyamine path ways, Proc. Natl. Acad. Sci., 2001; 98(13): 7301-7306.
79. Zhang X.J., Chinkes D.L., Wu Z. and Herndon D.N., Enternal L-Arg supplementation stimulates DNA synthesis in skin donor wound, Clin. Nutr., 2011; 30: 391-396
80. Pegg A.E. and McCann P.P., Polyamine metabolism and function, Am. J. Physiol. Cell Physiol., 1982; 243: C212-221.